Krajina: Singapur
Jazyk: angličtina
Zdroj: HSA (Health Sciences Authority)
ROPIVACAINE HCl
DCH AURIGA SINGAPORE
Pending
2 mg/ml
INJECTION
ROPIVACAINE HCl 2 mg/ml
SUBCUTANEOUS, EPIDURAL
Prescription Only
ASTRAZENECA PTY LTD
ACTIVE
1997-03-26
Naropin £ £ Product Information 1 (23) NAROPIN (Ropivacaine Hydrochloride) PRODUCT INFORMATION (Injection solutions for the production of local or regional anaesthesia) NOT FOR INTRAVENOUS ADMINISTRATION UNDER ANY CIRCUMSTANCES NAME OF THE MEDICINE The active ingredient in NAROPIN £ is ropivacaine hydrochloride. The CAS number for the free base is 84057-95-4. The chemical formula of ropivacaine hydrochloride is C 17 H 26 N 2 O.HCl.H 2 O. The chemical structure of ropivacaine hydrochloride is: H N H CH 3 CH 3 O N CH 2 CH 2 CH 3 * HCL DESCRIPTION The chemical name for ropivacaine hydrochloride is (S)-(-)-propyl-piperidine-2- carboxylic acid (2,6-dimethyl-phenyl)-amide hydrochloride monohydrate. It is a white crystalline powder and has a water solubility of about 50 mg/mL. Ropivacaine hydrochloride was developed as the pure S-(-)-isomer and has an enantiomeric purity of > 99%. It has a pKa of 8.1 (at 25 qC) and a molecular weight of 328.89. The pH of a saturated solution of ropivacaine hydrochloride is 4.5 and that of a 1% (w/v) aqueous solution is 5.0. NAROPIN solution for injection is a sterile, isotonic, isobaric, aqueous solution of ropivacaine HCl in Water for Injections BP. The pH of the solution is adjusted with sodium hydroxide or hydrochloric acid to remain between 4.0 - 6.0 during the approved shelf-life. The nominal osmolality of NAROPIN 0.2% (2 mg/mL) is 288 mosmol/kg. The solution is preservative free. The presentations of NAROPIN injection solutions are intended for single use only. Any solution remaining from an opened container should be discarded. PHARMACOLOGY Naropin £ £ Product Information 2 (23) Ropivacaine has both anaesthetic and analgesic effects. At higher doses it produces surgical anaesthesia with motor block, while at lower doses it p Prečítajte si celý dokument
NAROPIN (Ropivacaine Hydrochloride) PRODUCT INFORMATION (Injection solutions for the production of local or regional anaesthesia) NOT FOR INTRAVENOUS ADMINISTRATION UNDER ANY CIRCUMSTANCES NAME OF THE MEDICINE The active ingredient in NAROPIN is ropivacaine hydrochloride. The CAS number for the free base is 84057-95-4. The chemical formula of ropivacaine hydrochloride is C 17 H 26 N 2 O.HCl.H 2 O. The chemical structure of ropivacaine hydrochloride is: DESCRIPTION The chemical name for ropivacaine hydrochloride is (S)-(-)-propyl-piperidine-2-carboxylic acid (2,6-dimethyl-phenyl)-amide hydrochloride monohydrate. It is a white crystalline powder and has a water solubility of about 50 mg/mL. Ropivacaine hydrochloride was developed as the pure S-(-)-isomer and has an enantiomeric purity of > 99%. It has a pKa of 8.1 (at 25 °C) and a molecular weight of 328.89. The pH of a saturated solution of ropivacaine hydrochloride is 4.5 and that of a 1% (w/v) aqueous solution is 5.0. NAROPIN solution for injection is a sterile, isotonic, isobaric, aqueous solution of ropivacaine HCl in Water for Injections BP. The pH of the solution is adjusted with sodium hydroxide or hydrochloric acid to remain between 4.0 - 6.0 during the approved shelf-life. The nominal osmolality of NAROPIN 0.2% (2 mg/mL) is 288 mosmol/kg. The solution is preservative free. The presentations of NAROPIN injection solutions are intended for single use only. Any solution remaining from an opened container should be discarded. PHARMACOLOGY Ropivacaine has both anaesthetic and analgesic effects. At higher doses it produces surgical anaesthesia with motor block, while at lower doses it produces a sensory block including analgesia with little motor block. The duration and intensity of ropivacaine sensory block is not improved by the addition of adrenaline. Ropivacaine, like other local anaesthetics, causes reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the cell membrane of the nerve fibres. Prečítajte si celý dokument